R.G. Niederhoffer Capital Management’s Gilead Sciences GILD Stock Holding History

R.G. Niederhoffer Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,000	Closed	-$309K	–	8
2018 Q3	$309K	Buy	+4,000	New	+$302K	1.83%	18
2017 Q2	–	Sell	-15,500	Closed	-$1.05M	–	25
2017 Q1	$1.05M	Buy	+15,500	New	+$1.09M	6.78%	3
2016 Q3	–	Sell	-11,700	Closed	-$976K	–	32
2016 Q2	$976K	Buy	+11,700	New	+$1.04M	6.19%	6
2015 Q4	–	Sell	-25,100	Closed	-$2.46M	–	11
2015 Q3	$2.46M	Buy	25,100 +9,500	+61%	+$1.06M	12.17%	1
2015 Q2	$1.83M	Buy	+15,600	New	+$1.7M	11.5%	2
2014 Q2	–	Sell	-26,500	Closed	-$1.88M	–	34
2014 Q1	$1.88M	Buy	+26,500	New	+$2.08M	7.66%	1

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

R.G. Niederhoffer Capital Management's GILD Position: Q4 2018 in Review

R.G. Niederhoffer Capital Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 4,000 shares — an estimated $309K sold.

R.G. Niederhoffer Capital Management first reported a position in GILD in Q1 2014 and held it in 6 quarters. The position peaked at $2.46M in Q3 2015. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

R.G. Niederhoffer Capital Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
R.G. Niederhoffer Capital Management sold 4,000 Gilead Sciences shares in Q4 2018, an estimated $309K.
R.G. Niederhoffer Capital Management first reported a position in Gilead Sciences in Q1 2014 and held it in 6 quarters.
R.G. Niederhoffer Capital Management's Gilead Sciences position peaked at $2.46M in Q3 2015.
1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on R.G. Niederhoffer Capital Management's 13F filing for Q4 2018.